4//SEC Filing
BB BIOTECH AG 4
Accession 0000899243-22-030031
CIK 0001428522other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 12:05 PM ET
Size
7.5 KB
Accession
0000899243-22-030031
Insider Transaction Report
Form 4
BB BIOTECH AG
10% Owner
Transactions
- Disposition from Tender
Common Stock
2022-08-11$10.00/sh−8,733,538$87,335,380→ 0 total
BIOTECH TARGET N V
10% Owner
Transactions
- Disposition from Tender
Common Stock
2022-08-11$10.00/sh−8,733,538$87,335,380→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of June 23, 2022, by and among the Issuer, Ginger Acquisition, Inc. ("Parent") and Ginger Merger Sub, Inc. ("Purchaser"), the Issuer merged with and into Purchaser on August 15, 2022, following a tender offer by Purchaser (the "Offer") to purchase each outstanding share of the Issuer's common stock in exchange for (i) $10.00, in cash, without interest and less applicable tax withholdings, plus (ii) one contractual contingent value right, which represents the right to receive a contingent payment of $1.00 (without interest thereon) upon the satisfaction of certain conditions (collectively, the "Offer Price"). Pursuant to the Merger Agreement and the Offer, the Purchaser acquired all of the shares of the Company held by the Reporting Persons and merged with and into the Issuer.
Documents
Issuer
Radius Health, Inc.
CIK 0001428522
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0000924223
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 12:05 PM ET
- Size
- 7.5 KB